Knowledgebase for Trademark & Intellectual Property.

This a problem about ethics in business and intellectual properties in a pharmaceutical company?

By Yahoo User • Category: Patents Lawsuit

2 researchers,one is Dr.Adam n n da other is Dr.Badul went on to do a research about anti retro-viral treatment in two different companies. Both r friends.Dr.Adam is the CEO of company Comel n Dr.Badul is the head of researcher in company Dent. Dr.Badul was expelled by company Dent because being alleged of disclosure of some research findings to another competitor and soon was offered by Dr.Adam to do a collabo with him. Dr. Badul told that he was on his way to finished his final research findings when he was expelled.The findings are still with his former company.They soon finalised their research and produce a new anti-retroviral called LayanJer and managed to secure a deal with the government to sell their to all the hospital in government and private sector.The problem are1. that as soon as company Comel launch its to the public,Company Dent claims that da LayanJer produce by company Comel copycat its similar to then called Yezza. Dr. Badul claim that the similarities are coincidental when he was asked to defend his right during company Comel EGM.2.Company Dent filed a complaints to the Ministry of Trade against company Comel for patent right violation and also to the Ministry of Health for marketing LayanJer without approval.3.Company Comel is also facing a multi million lawsuit by company Dent for manufacturing and distribution of LayanJer as compared to Yezza.How to solve this problems ethically and who is right and who is wrong in this case?

One Response »

  1. The company where the anti-retroviral was discovered is by most laws worldwide, the rightful proprietor of the agent. Any claims otherwise, would be thwarted by documentation of who produced the agent first. Whoever can prove that they created the agent first, should prevail.

Questions & Answers are Powered by Yahoo! Answers